Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1995

Primary Completion Date

February 28, 2001

Conditions
Ovarian Cancer
Interventions
DRUG

aminocamptothecin

Trial Locations (6)

10016

NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York

10021

New York Presbyterian Hospital - Cornell Campus, New York

10029

Mount Sinai Medical Center, NY, New York

10461

Albert Einstein Comprehensive Cancer Center, The Bronx

07701

Riverview Medical Center, Red Bank

07902-0220

Overlook Hospital, Summit

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Eastern Cooperative Oncology Group

NETWORK

lead

NYU Langone Health

OTHER

NCT00002671 - Aminocamptothecin in Treating Patients With Recurrent or Unresectable Epithelial Ovarian Cancer | Biotech Hunter | Biotech Hunter